Neoplasms, Glandular and Epithelial Clinical Trials

30 clinical trials for Neoplasms, Glandular and Epithelial across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors — RECRUITING · PHASE1
• Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study — RECRUITING · NA
• Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer — RECRUITING · PHASE2
• Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance — NOT_YET_RECRUITING · PHASE2
• Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP) — ACTIVE_NOT_RECRUITING · PHASE2
• Vorasidenib Expanded Access Program — OTHER
• Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma — ACTIVE_NOT_RECRUITING · NA
• Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy — COMPLETED · NA
• Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc) — TERMINATED · PHASE2
• AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors — COMPLETED · PHASE1
• Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Intended Use Study of the BD SurePath Plus™ Pap — TERMINATED
• Study of the Safety of VB6-845 in Patients With Advanced Solid Tumours of Epithelial Origin — TERMINATED · PHASE1
• Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer — COMPLETED · PHASE2
• Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors — COMPLETED · PHASE1
• A Study of Overall Survival in Participants With Unresectable Hepatocellular Carcinoma — COMPLETED
• Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• HR Versus RFA for HCC in Patients With PHT — OTHER · PHASE3
• Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer — OTHER · PHASE2
• Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer — OTHER · PHASE2
• A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer — TERMINATED · PHASE2
• Low Rectal Cancer Study (MERCURY II) — OTHER
• Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks — OTHER · PHASE2
• Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial — OTHER
• BowelScope: Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities — COMPLETED · NA
• Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED) — COMPLETED · PHASE3
• Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025) — COMPLETED · PHASE3
• Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) — TERMINATED · PHASE3
• Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma — OTHER · PHASE2

Refine this search